Larsen TS - Search Results

1

Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review.

Jelicic J, Larsen TS, Fialla AD, Bukumiric Z, Andjelic B. Jelicic J, et al. Among authors: larsen ts. Clin Lymphoma Myeloma Leuk. 2022 Nov;22(11):e981-e991. doi: 10.1016/j.clml.2022.07.006. Epub 2022 Jul 17. Clin Lymphoma Myeloma Leuk. 2022. PMID: 35948478 Review.

2

Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review.

Jelicic J, Larsen TS, Maksimovic M, Trajkovic G. Jelicic J, et al. Among authors: larsen ts. Crit Rev Oncol Hematol. 2019 Jan;133:1-16. doi: 10.1016/j.critrevonc.2018.10.006. Epub 2018 Nov 1. Crit Rev Oncol Hematol. 2019. PMID: 30661646

3

Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study.

Clausen MR, Ulrichsen SP, Larsen TS, Poulsen CB, Tojaga S, Pedersen PT, Madsen J, Pedersen RS, Josefsson PL, Gørløv JS, Nørgaard M, d'Amore F. Clausen MR, et al. Among authors: larsen ts. Leuk Lymphoma. 2019 Aug;60(8):1950-1957. doi: 10.1080/10428194.2018.1554863. Epub 2019 Jan 22. Leuk Lymphoma. 2019. PMID: 30668181

4

Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models - A Systematic Review.

Jelicic J, Larsen TS, Frederiksen H, Andjelic B, Maksimovic M, Bukumiric Z. Jelicic J, et al. Among authors: larsen ts. Clin Epidemiol. 2020 May 27;12:537-555. doi: 10.2147/CLEP.S244294. eCollection 2020. Clin Epidemiol. 2020. PMID: 32581596 Free PMC article. Review.

5

Impact of C-reactive protein and albumin levels on short, medium, and long term mortality in patients with diffuse large B-cell lymphoma.

Gradel KO, Larsen TS, Frederiksen H, Vinholt PJ, Iachina M, Póvoa P, Zampieri FG, Nielsen SL, Dessau RB, Møller JK, Jensen TG, Chen M, Coia JE, Jelicic J. Gradel KO, et al. Among authors: larsen ts. Ann Med. 2022 Dec;54(1):713-722. doi: 10.1080/07853890.2022.2046287. Ann Med. 2022. PMID: 35238275 Free PMC article.

6

Bone marrow biopsy can be omitted in the diagnostic workup of CNS lymphoma of DLBCL origin: a population-based retrospective study in the PET-CT era.

Jelicic J, Hansen DL, Carlsen SS, Thorsgaard M, Hersby DS, Kannik K, Munksgaard ASE, Larsen TS, Juul-Jensen K. Jelicic J, et al. Among authors: larsen ts. Ann Hematol. 2023 Jul;102(7):1897-1905. doi: 10.1007/s00277-023-05282-7. Epub 2023 May 29. Ann Hematol. 2023. PMID: 37246974 Free PMC article.

7

Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas.

Al-Mashhadi AL, Jakobsen LH, Brown P, Gang AO, Thorsteinsson AL, Rasoul K, Haissman JM, Tøstesen MB, Christoffersen MN, Jelicic J, Jørgensen JB, Thomsen T, Dessau-Arp A, Andersen APH, Frederiksen M, Pedersen PT, Clausen MR, Jørgensen JM, Poulsen CB, El-Galaly TC, Larsen TS. Al-Mashhadi AL, et al. Among authors: larsen ts. Br J Haematol. 2024 Mar;204(3):839-848. doi: 10.1111/bjh.19201. Epub 2023 Nov 27. Br J Haematol. 2024. PMID: 38009548

8

Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms.

Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, Kruse TA, Hasselbalch HC. Skov V, et al. Among authors: larsen ts. Leuk Lymphoma. 2012 Jan;53(1):123-9. doi: 10.3109/10428194.2011.597905. Epub 2011 Aug 1. Leuk Lymphoma. 2012. PMID: 21806350

9

Minimal residual disease after long-term interferon-alpha2 treatment: a report on hematological, molecular and histomorphological response patterns in 10 patients with essential thrombocythemia and polycythemia vera.

Utke Rank C, Weis Bjerrum O, Larsen TS, Kjær L, de Stricker K, Riley CH, Hasselbalch HC. Utke Rank C, et al. Among authors: larsen ts. Leuk Lymphoma. 2016 Feb;57(2):348-354. doi: 10.3109/10428194.2015.1049171. Epub 2015 Jun 18. Leuk Lymphoma. 2016. PMID: 25956046

10

Risk of death, relapse or progression, and loss of life expectancy at different progression-free survival milestones in primary central nervous system lymphoma.

Biccler JL, Savage KJ, Brown PDN, Jørgensen J, Larsen TS, Poulsen CB, Stoltenberg D, Sehn LH, Scott DW, Gerrie AS, Jakobsen LH, Bøgsted M, El-Galaly TC, Villa D. Biccler JL, et al. Among authors: larsen ts. Leuk Lymphoma. 2019 Oct;60(10):2516-2523. doi: 10.1080/10428194.2019.1594219. Epub 2019 Apr 3. Leuk Lymphoma. 2019. PMID: 30943052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

192 results

Search Page